title: Part two: against the motion. endovascular therapy is the preferred treatment for patients <65 years old with symptomatic infrainguinal arterial disease.
authors.affiliation: Division of Vascular & Endovascular Surgery of the General Surgical Services, Massachusetts General Hospital, Boston, MA 02114, USA.
authors.forename: R
authors.initials: R
authors.lastname: Houbballah
authors.forename: M
authors.initials: M
authors.lastname: Raux
authors.forename: G
authors.initials: G
authors.lastname: LaMuraglia
mesh_terms: D000367:Age Factors; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D057510:Endovascular Procedures / Q000009:adverse effects / Q000191:economics; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006801:Humans; D007383:Intermittent Claudication / Q000191:economics / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D007511:Ischemia / Q000191:economics / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D023821:Limb Salvage; D035002:Lower Extremity / Q000098:blood supply*; D008875:Middle Aged; D018579:Patient Selection; D058729:Peripheral Arterial Disease / Q000150:complications / Q000191:economics / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014654:Vascular Patency; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000191:economics